Cargando…
Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia
BACKGROUND: Enterococci are commensal of the gastrointestinal tract known to cause blood stream infections (BSIs). Studies have shown increased mortality from enterococcal BSI in neutropenic patients, indicating Vancomycin-resistant Enterococcal (VRE) infections causing increased mortality. Whether...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631794/ http://dx.doi.org/10.1093/ofid/ofx163.647 |
_version_ | 1783269560662622208 |
---|---|
author | Addisu, Anteneh Hackney, Noah Nanjappa, Somya Cheema, Asima Greene, John |
author_facet | Addisu, Anteneh Hackney, Noah Nanjappa, Somya Cheema, Asima Greene, John |
author_sort | Addisu, Anteneh |
collection | PubMed |
description | BACKGROUND: Enterococci are commensal of the gastrointestinal tract known to cause blood stream infections (BSIs). Studies have shown increased mortality from enterococcal BSI in neutropenic patients, indicating Vancomycin-resistant Enterococcal (VRE) infections causing increased mortality. Whether these differences in mortality apply to AML patients is unknown. The objectives of this study are to compare the risk factors and outcomes between VRE & VSE BSIs in AML patients. METHODS: We conducted a single center, retrospective cohort study of patients with enterococcal BSIs at H. Lee Moffitt Cancer Center from July 2011 to October 2015. Records were searched to identify AML patients with enterococcal BSI. Enterococcal species, neutropenia duration, Vancomycin exposure, VRE colonization, 7 and 30 day mortality, age, sex, length of stay, stem cell transplant & central line status were compared. We conducted statistical tests and Kaplan-Meier plot to analyze mortality trends. RESULTS: There were a total of 77 AML patients with enterococcal BSI. Forty-two (54.5%) were caused by VRE. E. faecalis and E. faecium accounted for 28.5% and 62.3% of BSI respectively. The E. faecalis isolates were more likely to be VSE (83% vs. 8.3 %, P < 0.001) and E. fecium isolates to be VRE (71% vs. 29%, P < 0.001). Duration of neutropenia was significantly longer (27.3 vs. 20.7 days, P < 0.005) among AML patients with VRE BSI. Recent Vancomycin use and VRE colonization were significantly associated with VRE BSI. There were no significant differences in duration of bacteremia, length of stay and 7 and 30-day mortality between VRE vs. VSE BSI. CONCLUSION: Enterococcal infections among AML patients are significantly more likely to be caused by Vancomycin-resistant E. faecium. The risk is increased by VRE colonization and Vancomycin exposure. The absence of statistical difference in 7 or 30-day mortality between VRE and VSE enterococcal BSI in our AML patients could indicate that in a homogenous group of patients, host and treatment-related factors may influence mortality more than species or susceptibility of the isolates. Our finding confirms VRE colonization as risk factor of VRE BSI for AML patients. This finding is important for future patient education and development of preventive and treatment protocols. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-5631794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56317942017-11-07 Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia Addisu, Anteneh Hackney, Noah Nanjappa, Somya Cheema, Asima Greene, John Open Forum Infect Dis Abstracts BACKGROUND: Enterococci are commensal of the gastrointestinal tract known to cause blood stream infections (BSIs). Studies have shown increased mortality from enterococcal BSI in neutropenic patients, indicating Vancomycin-resistant Enterococcal (VRE) infections causing increased mortality. Whether these differences in mortality apply to AML patients is unknown. The objectives of this study are to compare the risk factors and outcomes between VRE & VSE BSIs in AML patients. METHODS: We conducted a single center, retrospective cohort study of patients with enterococcal BSIs at H. Lee Moffitt Cancer Center from July 2011 to October 2015. Records were searched to identify AML patients with enterococcal BSI. Enterococcal species, neutropenia duration, Vancomycin exposure, VRE colonization, 7 and 30 day mortality, age, sex, length of stay, stem cell transplant & central line status were compared. We conducted statistical tests and Kaplan-Meier plot to analyze mortality trends. RESULTS: There were a total of 77 AML patients with enterococcal BSI. Forty-two (54.5%) were caused by VRE. E. faecalis and E. faecium accounted for 28.5% and 62.3% of BSI respectively. The E. faecalis isolates were more likely to be VSE (83% vs. 8.3 %, P < 0.001) and E. fecium isolates to be VRE (71% vs. 29%, P < 0.001). Duration of neutropenia was significantly longer (27.3 vs. 20.7 days, P < 0.005) among AML patients with VRE BSI. Recent Vancomycin use and VRE colonization were significantly associated with VRE BSI. There were no significant differences in duration of bacteremia, length of stay and 7 and 30-day mortality between VRE vs. VSE BSI. CONCLUSION: Enterococcal infections among AML patients are significantly more likely to be caused by Vancomycin-resistant E. faecium. The risk is increased by VRE colonization and Vancomycin exposure. The absence of statistical difference in 7 or 30-day mortality between VRE and VSE enterococcal BSI in our AML patients could indicate that in a homogenous group of patients, host and treatment-related factors may influence mortality more than species or susceptibility of the isolates. Our finding confirms VRE colonization as risk factor of VRE BSI for AML patients. This finding is important for future patient education and development of preventive and treatment protocols. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5631794/ http://dx.doi.org/10.1093/ofid/ofx163.647 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Addisu, Anteneh Hackney, Noah Nanjappa, Somya Cheema, Asima Greene, John Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia |
title | Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia |
title_full | Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia |
title_fullStr | Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia |
title_full_unstemmed | Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia |
title_short | Risk Factors and Outcomes of Vancomycin-Resistant vs. Vancomycin-Sensitive Enterococcal Blood Stream Infections in Patients with Acute Myeloid Leukemia |
title_sort | risk factors and outcomes of vancomycin-resistant vs. vancomycin-sensitive enterococcal blood stream infections in patients with acute myeloid leukemia |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631794/ http://dx.doi.org/10.1093/ofid/ofx163.647 |
work_keys_str_mv | AT addisuanteneh riskfactorsandoutcomesofvancomycinresistantvsvancomycinsensitiveenterococcalbloodstreaminfectionsinpatientswithacutemyeloidleukemia AT hackneynoah riskfactorsandoutcomesofvancomycinresistantvsvancomycinsensitiveenterococcalbloodstreaminfectionsinpatientswithacutemyeloidleukemia AT nanjappasomya riskfactorsandoutcomesofvancomycinresistantvsvancomycinsensitiveenterococcalbloodstreaminfectionsinpatientswithacutemyeloidleukemia AT cheemaasima riskfactorsandoutcomesofvancomycinresistantvsvancomycinsensitiveenterococcalbloodstreaminfectionsinpatientswithacutemyeloidleukemia AT greenejohn riskfactorsandoutcomesofvancomycinresistantvsvancomycinsensitiveenterococcalbloodstreaminfectionsinpatientswithacutemyeloidleukemia |